Журнал клинических испытаний
Открытый доступ

Абстрактный

Being Principal Investigators on Pharma-initiated Clinical Trials: Have we Sold Ourselves Too Cheap?

Leibowitz-Amit R

The other day in clinic I was going through one of those good-clinical-practice (GCP) modules, as requested by one of the pharma companies in order for me to participate as an investigator in one of their clinical trial. As I repetitively wasn't able to correctly answer the minimum 80% of the questions needed for me to pass the final test of the module, my morning hours just flew by, and with my increasing level of anxiety, it suddenly dawned on me-we, physician-investigators participating in pharma-initiated clinical trials, have sold ourselves too cheap.